Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers
+ Sample video: contact me for sample video
+ Information:
Contemporary Management of Cardiovascular Disease in Women
September 26, 2026
This symposium provides healthcare professionals with an evidence-based review of cardiovascular disease in women, emphasizing sex-specific differences in risk factors, clinical presentation, diagnosis, prevention, and treatment. Expert speakers will discuss current guidelines, emerging research, and best practices for recognizing atypical presentations and addressing healthcare disparities. Through case-based discussions and practical applications, participants will gain the knowledge and skills needed to improve the prevention, early detection, and management of cardiovascular disease in women, ultimately enhancing patient outcomes.
MAIN OBJECTIVE
The objective of this symposium is to educate healthcare providers on gender-specific approaches in prevention, diagnosis, and treatment of women with a broad range of cardiovascular diseases.
LEARNING OBJECTIVES
By the end of the symposium participants will be able to:
- Identify sex-specific risk factors and clinical presentations associated with cardiovascular disease in women.
- Apply current evidence-based guidelines for the prevention, diagnosis, and management of cardiovascular disease in women across their lifespan.
- Develop patient-centered strategies to improve cardiovascular risk assessment, education, and outcomes for women in diverse clinical settings.
NEEDS ASSESSMENT
Cardiovascular disease (CVD) is the leading cause of death among women, yet it continues to be under-recognized, under-diagnosed, and under-treated. Women often present with atypical symptoms and have unique risk factors related to pregnancy, menopause, autoimmune disorders, and hormonal changes that may delay diagnosis and treatment. Healthcare professionals require updated knowledge on sex-specific cardiovascular risk assessment, evidence-based prevention strategies, and current treatment guidelines to improve early recognition, reduce disparities in care, and optimize outcomes for women with cardiovascular disease.
TARGET AUDIENCE
This program has been designed to provide primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists and other healthcare providers with the necessary information to increase knowledge and awareness of cardiovascular disease in women with the goal of improving patient care.
+ Topics:
Saturday, September 26, 2026
7:00am Registration/Visit Exhibits
7:15-7:45 Coffee Convocation Lecture The State of Women Cardiologists: Evidence, Equity, and Excellence Christina Economides, MD, MM, FSCAI Katrine Zhiroff, MD, MBA, FACC, FSCAI
7:45-8:45 Breakfast – Product Theatre (Non-CME) The Next Beat: KERENDIA (Finerenone) for Your Patients with Heart Failure (HF) with Left Ventricular Ejection Fraction (LVEF) >40% Speaker: Payal Kohli, MD, FACC Supported by: Bayer
8:45-8:55 Visit Exhibits
8:55-9:00 Welcome and Introductory Remarks Christina Economides, MD, MM, FSCAI
9:00-9:20 Intersection of Obesity and Heart Failure: Role of GLP1 Agonists Michelle Kittleson, MD, PhD
9:20-9:40 Pulmonary Arterial Hypertension (PAH): Call to Action for Early Diagnosis and Treatment Ronald Oudiz, MD
9:40-10:00 FDA Black Box Warning Removed: Changing Perspective on Safety of HRT in Postmenopausal Women Janet Wei, MD, FACC
10:00-10:20 Earlier Intervention: 2026 Dyslipidemia Guidelines Karol Watson, MD, PhD, FACC
10:20-10:30 Question & Answer
10:30-10:40 Break/Visit Exhibits
10:40-11:00 Atrial Fibrillation Ablation: Outcomes in Women Ravi Sureddi, MD
11:00-11:20 2026 Acute PE Guidelines: Sex Differences in Prevalence, Presentation and Treatment Nichelle Megowan, MD
11:20-11:40 Lifetime Management of Aortic Stenosis Katrine Zhiroff, MD, MBA, FACC, FSCAI
11:40-12:00 Tricuspid Valve: Identifying Candidates for Advanced Device Therapies Steven Burstein, MD
12:00-12:10 Question & Answer
12:10-1:10 Lunch – Product Theatre (Non-CME) Unmasking hATTR Polyneuropathy Speaker: Dr. Vasvi Singh Supported by: AstraZeneca
1:10-1:20 Break/Visit Exhibits
1:20-1:35 Cardiovascular Disease in Women: 2026 Update Christina Economides, MD, MM, FSCAI
1:35-1:50 Treatment of Cardiovascular-Kidney-Metabolic (CKM) Syndrome Christina Economides, MD, MM, FSCAI
1:50-2:10 Clinical Approach to the Diagnosis and Treatment of Cardiac Amyloidosis Joseph Rahman, MD
2:10-2:30 Peripartum Cardiomyopathy with Improved EF: A Recovery or Remission Uri Elkayam, MD, FACC
2:30-3:00 Hypertrophic Cardiomyopathy in Women, Prevalence and Presentation New Therapeutic Approach: Invasive versus Medical Evidence and Clinical Experience Joseph Rahman, MD Katrine Zhiroff, MD, MBA, FACC, FSCAI
3:00-3:10 Question & Answer
3:10-3:20 Break/Visit Exhibits
3:20-4:10 Vignettes: Clinical Decision-Making for Coronary Artery Disease Drug-Coated Balloon Angioplasty
- Intravascular Lithotripsy for Calcified CAD in Women
- Mechanical Circulatory Support for High-Risk PCI
- Revascularization in Ischemic Cardiomyopathy
Moderators:
Christina Economides, MD, MM, FSCAI
Katrine Zhiroff, MD, MBA, FACC, FSCAI
4:10-4:25 Question & Answer
4:25-4:30 Closing Remarks
4:30 Adjourn
Reviews
There are no reviews yet.